|Chemical Names:||Boldenone undecylenate; 13103-34-9; Parenabol; 17b-[(1-Oxo-10-undecenyl)oxy]-androsta-1,4-dien-3-one; UNII-ZS6D2ITA30; More…|
|Molecular Weight:||452.679 g/mol|
|Substance Registry:||FDA UNII|
|Safety Summary:||Laboratory Chemical Safety Summary (LCSS)|
Like other AAS, boldenone is an agonist of the androgen receptor (AR). The activity of boldenone is mainly anabolic, with a low androgenic potency. Boldenone will increase nitrogen retention, protein synthesis, increases appetite and stimulates the release of erythropoietin in the kidneys. Boldenone was synthesized in an attempt to create a long-acting injectable metandienone, for androgen deficiency disorders. Boldenone acts similar to metandienone with fewer adverse androgenic effects.[medical citation needed] Although commonly compared to nandrolone, boldenone lacks progesterone receptor interaction and associated progestogenic side effects.
EquiTREX 350® – Boldenone Undeclynate 350mg / 1ml, 10ml vials